Saturday, July 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Cyber Security

CrowdStrike’s Post-Split Volatility Masks Sector-Wide Cybersecurity Selloff as Analysts Stay Bullish

SiterGedge by SiterGedge
July 11, 2026
in Cyber Security, Market Commentary, Nasdaq, Tech & Software
0
CrowdStrike Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

The broader US market enjoyed a relief rally on Friday, with the S&P 500 adding 0.42% and the Dow Jones climbing 0.29% as geopolitical tensions eased. Yet CrowdStrike — and indeed much of the cybersecurity sector — moved in the opposite direction. The stock tumbled 5.63% to close at €163.84, losing roughly $11 billion in market value in a single session. That contrasts sharply with the 16.80% gain the shares had racked up over the prior 30 days and leaves them down 4.47% on the week.

No company-specific news triggered the selloff. Market participants attributed the move to a combination of profit-taking after a strong run and technical noise around CrowdStrike’s 4-for-1 stock split, which took effect on July 2. The lower post-split price per share tends to attract retail interest but also invites short-term profit-takers to exit. Adding to the narrative, CEO George Kurtz sold shares on July 9, one day before the steeper decline; he still holds over eight million shares. The broader cybersecurity sector also bucked the market’s positive trend, suggesting a rotation out of the group rather than a company-specific problem.

Despite the abrupt drop, the technical picture remains largely intact. The stock trades above all major moving averages — 3.7% above its 20-day line and 14.9% above its 50-day average of $163.23. A golden cross formed in May, and the MACD indicator sits above its signal line with a positive histogram. The 14-day relative strength index stands at 56.7, a neutral reading that leaves room in either direction. Yet the annualized 30-day volatility of 45.28% underscores how jittery the stock has become since the split took effect.

Should investors sell immediately? Or is it worth buying CrowdStrike?

Wall Street analysts largely shrugged off the pullback. Benchmark raised its price target to $230 from $195 and reiterated a buy rating. Morgan Stanley trimmed its target ever so slightly to $172 from $172.50 but kept its “Overweight” stance. Needham held firm at $235 with a buy recommendation, viewing Friday’s decline as a sector-wide revaluation rather than a sign of fundamental weakness. The divergence among targets — from $172 to $235 — reflects varying views on near-term momentum, but the overall tone remains constructive.

CrowdStrike’s weight in key cybersecurity exchange-traded funds means the volatility ripples well beyond the single stock. It accounts for 8.81% of the First Trust NASDAQ Cybersecurity ETF, 6.02% of the Amplify Cybersecurity ETF, and 5.79% of the Global X Cybersecurity ETF. With a market capitalization of roughly €176.84 billion ($186 billion at current rates), the company remains one of the sector’s largest constituents — and its daily swings translate directly into fund performance.

On the weekly chart, support lies near €154.50, with additional backing around the 50-day moving average. Resistance is pegged at €196.50, just below the psychologically important €200 mark, while the 52-week high of €209.50 remains out of reach for now. The 30-day return of nearly 17% suggests Friday’s pullback is a breather within a larger uptrend rather than a reversal. Still, with volatility this elevated and insider selling in the rearview mirror, the coming days will test whether buyers step in to defend recent gains or whether the consolidation deepens toward the moving averages.

Ad

CrowdStrike Stock: Buy or Sell?! New CrowdStrike Analysis from July 11 delivers the answer:

The latest CrowdStrike figures speak for themselves: Urgent action needed for CrowdStrike investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 11.

CrowdStrike: Buy or sell? Read more here...

Tags: CrowdStrike
SiterGedge

SiterGedge

Related Posts

Alibaba Stock
AI & Quantum Computing

AI Factories, Buybacks, and a Legal Settlement: The Three Pillars Behind Alibaba’s Weekly Surge

July 11, 2026
Palantir Stock
Analysis

Palantir’s Summer of Contradictions: Record Contracts, a CEO Feud, and a Stock Going Nowhere

July 11, 2026
Navitas Semiconductor Corporation Stock
AI & Quantum Computing

Patent Lawsuit and Index Removal Derail Navitas Semiconductor’s AI Data Center Dreams

July 11, 2026
Next Post
Sellas Life Sciences Stock

Sellas Life Sciences Holds Its Breath as a Leukemia Trial Nears the Finish Line

Navitas Semiconductor Corporation Stock

Patent Lawsuit and Index Removal Derail Navitas Semiconductor's AI Data Center Dreams

Palantir Stock

Palantir’s Summer of Contradictions: Record Contracts, a CEO Feud, and a Stock Going Nowhere

Recommended

Pfizer Stock

Is Pfizer Stock Poised for a Rebound? Obesity Drugs Spark Renewed Optimism

8 months ago
First Commonwealth Stock

First Commonwealth Stock: A Clash of Convictions Between Insiders and Institutions

10 months ago
Redcare Pharmacy Stock

Redcare Pharmacy Shares Plunge Amid Deepening Investor Doubts

8 months ago
Finance_ projections

Great Elm Capital Reports Strong Financial Performance and Strategic Initiatives for Growth

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Sellas Life Sciences Holds Its Breath as a Leukemia Trial Nears the Finish Line

CrowdStrike’s Post-Split Volatility Masks Sector-Wide Cybersecurity Selloff as Analysts Stay Bullish

Valneva’s Binary Outlook: A Broken Commercial Business Versus a Potentially Blockbuster Pipeline

Lam Research: Analyst Price Targets Soar to $425 as the Stock Holds Its Breath

The $650 Billion Question Behind This Quarter’s Rally

Broadcom’s Longest Bet Yet: A $30 Billion Apple Pact Runs Through 2031 While AI Custom Silicon Hits Stride

Trending

Alibaba Stock
AI & Quantum Computing

AI Factories, Buybacks, and a Legal Settlement: The Three Pillars Behind Alibaba’s Weekly Surge

by Jackson Burston
July 11, 2026
0

Alibaba’s stock has clawed back 14.34 percent in a single week, closing at €98.10 in Frankfurt on...

Palantir Stock

Palantir’s Summer of Contradictions: Record Contracts, a CEO Feud, and a Stock Going Nowhere

July 11, 2026
Navitas Semiconductor Corporation Stock

Patent Lawsuit and Index Removal Derail Navitas Semiconductor’s AI Data Center Dreams

July 11, 2026
Sellas Life Sciences Stock

Sellas Life Sciences Holds Its Breath as a Leukemia Trial Nears the Finish Line

July 11, 2026
CrowdStrike Stock

CrowdStrike’s Post-Split Volatility Masks Sector-Wide Cybersecurity Selloff as Analysts Stay Bullish

July 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • AI Factories, Buybacks, and a Legal Settlement: The Three Pillars Behind Alibaba’s Weekly Surge
  • Palantir’s Summer of Contradictions: Record Contracts, a CEO Feud, and a Stock Going Nowhere
  • Patent Lawsuit and Index Removal Derail Navitas Semiconductor’s AI Data Center Dreams

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com